1
/
of
0
FDA FAERS ICSR Source Documents – NAXITAMAB (Q3 2024; Case Nos: 24271071 & 24343373)
FDA FAERS ICSR Source Documents – NAXITAMAB (Q3 2024; Case Nos: 24271071 & 24343373)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: ICSR report source documents from FAERS Q3 2024 for NAXITAMAB, case numbers 24271071 and 24343373
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details